Cargando…
Clinical features and prognostic factors in Covid-19: A prospective cohort study
BACKGROUND: Mortality rates are high among hospitalized patients with COVID-19, especially in those intubated on the ICU. Insight in pathways associated with unfavourable outcome may lead to new treatment strategies. METHODS: We performed a prospective cohort study of patients with COVID-19 admitted...
Autores principales: | de Bruin, Sanne, Bos, Lieuwe D., van Roon, Marian A., Tuip-de Boer, Anita M., Schuurman, Alex R., Koel-Simmelinck, Marleen J.A., Bogaard, Harm Jan, Tuinman, Pieter Roel, van Agtmael, Michiel A., Hamann, Jörg, Teunissen, Charlotte E., Wiersinga, W. Joost, (Koos) Zwinderman, A.H., Brouwer, Matthijs C., van de Beek, Diederik, Vlaar, Alexander P.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118723/ https://www.ncbi.nlm.nih.gov/pubmed/34000622 http://dx.doi.org/10.1016/j.ebiom.2021.103378 |
Ejemplares similares
-
Complement inhibition in severe COVID-19 – Blocking C5a seems to be key
por: Lim, Endry H.T., et al.
Publicado: (2021) -
Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial
por: Lim, Endry H. T., et al.
Publicado: (2022) -
Efficacy matters: broadening complement inhibition in COVID-19 – Authors' reply
por: Vlaar, Alexander P J, et al.
Publicado: (2021) -
Sex steroid hormones are associated with mortality in COVID-19 patients: Level of sex hormones in severe COVID-19
por: van Zeggeren, Ingeborg E., et al.
Publicado: (2021) -
Inhibiting C5 in patients with severe COVID-19—the incorrect target?
por: Lim, Endry H T, et al.
Publicado: (2023)